Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer

NCT00002953 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

704

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cyclophosphamide
DRUG: epirubicin hydrochloride
DRUG: paclitaxel

Sponsor

Medical Research Council